|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.060 EUR | +2.01% |
|
-3.33% | +9.73% |
| 05-04 | MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-04 | MEDICLIN Aktiengesellschaft Revises Earnings Guidance for the Year 2026 | CI |
| Market Cap | 193M 223M 178M 166M 312M 21.22B 317M 2.1B 818M 10.33B 838M 820M 35.77B | P/E Ratio 2026 * |
-
| P/E Ratio 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 193M 223M 178M 166M 312M 21.22B 317M 2.1B 818M 10.33B 838M 820M 35.77B | EV / Sales 2026 * |
0.24x | EV / Sales 2027 * | 0.24x |
| Free-Float |
12.27% | Yield 2026 * |
0.99% | Yield 2027 * | 0.99% |
| 1 day | +2.01% | ||
| 1 week | -3.33% | ||
| Current month | +8.56% | ||
| 1 month | +12.15% | ||
| 3 months | +12.78% | ||
| 6 months | +7.98% | ||
| Current year | +9.73% |
| 1 week | 3.88 |  | 4.2 |
| 1 month | 3.52 | | 4.26 |
| Current year | 3.22 | | 4.26 |
| 1 year | 2.86 | | 4.26 |
| 3 years | 2.28 | | 4.26 |
| 5 years | 2.28 | | 4.28 |
| 10 years | 2.28 | | 6.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tino Marco Fritz
CEO | Chief Executive Officer | 49 | - |
Martin Buse
CMP | Compliance Officer | - | - |
Thomas Piefke
COO | Chief Operating Officer | - | 2023-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Hans Hilpert
BRD | Director/Board Member | 60 | 2002-12-31 |
Michael Bock
BRD | Director/Board Member | 63 | 2005-05-24 |
| Director/Board Member | 63 | 2012-09-19 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.01% | -3.33% | +37.16% | +33.55% | 223M | |
| +0.46% | +2.09% | +27.06% | +51.38% | 19.12B | |
| +0.06% | +2.33% | +21.50% | +69.65% | 12.86B | |
| +0.59% | -0.94% | -30.77% | -58.08% | 11.62B | |
| -0.89% | -2.44% | -16.09% | +57.46% | 10.07B | |
| +0.56% | -2.17% | -14.29% | -36.84% | 8.74B | |
| +1.52% | -12.29% | -1.24% | +61.18% | 8.66B | |
| +0.14% | +2.24% | +31.35% | +237.49% | 7.87B | |
| +5.77% | +5.26% | -9.84% | - | 6.65B | |
| +0.59% | +3.67% | +6.67% | -31.75% | 6.3B | |
| Average | +1.03% | -0.23% | +5.15% | +42.67% | 9.21B | |
| Weighted average by Cap. | +0.65% | -0.16% | +4.02% | +42.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 787M 912M 726M 679M 1.27B 86.66B 1.29B 8.57B 3.34B 42.18B 3.42B 3.35B 146B | 803M 930M 740M 693M 1.3B 88.4B 1.32B 8.74B 3.41B 43.03B 3.49B 3.42B 149B |
| Net income | 36.66M 42.45M 33.78M 31.62M 59.27M 4.03B 60.18M 399M 156M 1.96B 159M 156M 6.8B | 38.2M 44.22M 35.2M 32.95M 61.74M 4.2B 62.7M 416M 162M 2.05B 166M 162M 7.08B |
| Net Debt | - | - |
Employees
7,416
Calendar
07-29 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 4.060 € | +2.01% | 7,912 |
| 26-06-11 | 3.980 € | 0.00% | 644 |
| 26-06-10 | 3.980 € | -5.24% | 15,677 |
| 26-06-09 | 4.200 € | 0.00% | 8,625 |
| 26-06-08 | 4.200 € | 0.00% | 19,203 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.060EUR
Average target price
7.300EUR
Spread / Average Target
+79.80%
Net sales - Rate of surprise
- Stock Market
- Stocks
- MED Stock
Select your edition
All financial news and data tailored to specific country editions
